Skip to main content

Table 3 Blood catecholamine data for healthy adults consuming Capsimax™ and placebo in a randomized cross-over design

From: Effect of oral intake of capsaicinoid beadlets on catecholamine secretion and blood markers of lipolysis in healthy adults: a randomized, placebo controlled, double-blind, cross-over study

Variable Pre 2 hr
(pre-ex)
2.5 hr
(1 min post ex)
4 hr
(90 min post ex)
Epinephrine (pg·mL-1)
Capsimax™
41.54 ± 33.56 40.09 ± 29.83 69.34 ± 43.75 * 45.36 ± 39.36
Epinephrine (pg·mL-1)
Placebo
37.65 ± 27.16 36.54 ± 21.31 65.08 ± 51.10 * 34.49 ± 22.12
Norepinephrine (pg·mL-1)
Capsimax™
264.90 ± 132.66 378.63 ± 210.31** 491.08 ± 211.54** 440.10 ± 220.34 **
Norepinephrine (pg·mL-1)
Placebo
242.03 ± 157.63 326.84 ± 185.89** 553.53 ± 200.58** 344.61 ± 210.45**
  1. Data are Mean ± SD
  2. No interaction or condition effects were noted for EPI or NE (p > 0.05).
  3. * A time effect was noted for EPI (p < 0.0001); values higher than Pre at 2.5 hr.
  4. ** A time effect was noted for NE (p < 0.0001); values higher than Pre at 2 hr, 2.5 hr, and 4 hr.